LS Investment Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-47,829
| Closed | -$3.09M | – | 386 |
|
|
2021
Q1 | $3.09M | Sell |
47,829
-14,063
| -23% | -$907K | 0.17% | 133 |
|
|
2020
Q4 | $3.61M | Buy |
61,892
+1,881
| +3% | +$114K | 0.19% | 124 |
|
|
2020
Q3 | $3.79M | Buy |
60,011
+3,514
| +6% | +$244K | 0.22% | 117 |
|
|
2020
Q2 | $4.35M | Sell |
56,497
-46,433
| -45% | -$3.56M | 0.27% | 94 |
|
|
2020
Q1 | $7.7M | Sell |
102,930
-5,810
| -5% | -$401K | 0.56% | 41 |
|
|
2019
Q4 | $7.07M | Sell |
108,740
-717
| -0.7% | -$46.7K | 0.38% | 59 |
|
|
2019
Q3 | $6.94M | Sell |
109,457
-888
| -0.8% | -$58K | 0.41% | 54 |
|
|
2019
Q2 | $7.46M | Sell |
110,345
-339
| -0.3% | -$22.3K | 0.45% | 50 |
|
|
2019
Q1 | $7.2M | Sell |
110,684
-2,373
| -2% | -$158K | 0.45% | 49 |
|
|
2018
Q4 | $7.07M | Sell |
113,057
-7,259
| -6% | -$507K | 0.49% | 48 |
|
|
2018
Q3 | $9.29M | Sell |
120,316
-2,608
| -2% | -$197K | 0.53% | 45 |
|
|
2018
Q2 | $8.71M | Sell |
122,924
-8,015
| -6% | -$566K | 0.53% | 42 |
|
|
2018
Q1 | $9.87M | Sell |
130,939
-5,345
| -4% | -$425K | 0.59% | 41 |
|
|
2017
Q4 | $9.76M | Sell |
136,284
-99
| -0.1% | -$7.52K | 0.57% | 43 |
|
|
2017
Q3 | $11.1M | Sell |
136,383
-3,823
| -3% | -$292K | 0.66% | 34 |
|
|
2017
Q2 | $9.92M | Buy |
140,206
+2,275
| +2% | +$151K | 0.61% | 36 |
|
|
2017
Q1 | $9.37M | Buy |
137,931
+2,224
| +2% | +$156K | 0.6% | 40 |
|
|
2016
Q4 | $9.72M | Buy |
135,707
+921
| +0.7% | +$68.5K | 0.69% | 37 |
|
|
2016
Q3 | $10.7M | Sell |
134,786
-3,408
| -2% | -$277K | 0.78% | 29 |
|
|
2016
Q2 | $11.5M | Buy |
138,194
+2,391
| +2% | +$212K | 0.8% | 28 |
|
|
2016
Q1 | $12.5M | Buy |
135,803
+1,106
| +0.8% | +$99.7K | 0.93% | 21 |
|
|
2015
Q4 | $13.6M | Buy |
134,697
+109
| +0.1% | +$11.3K | 1.06% | 18 |
|
|
2015
Q3 | $13.2M | Sell |
134,588
-7,868
| -6% | -$874K | 1.06% | 16 |
|
|
2015
Q2 | $16.7M | Sell |
142,456
-4,023
| -3% | -$440K | 1.24% | 15 |
|
|
2015
Q1 | $14.4M | Sell |
146,479
-7,976
| -5% | -$810K | 1.1% | 19 |
|
|
2014
Q4 | $14.6M | Sell |
154,455
-2,570
| -2% | -$266K | 1.18% | 20 |
|
|
2014
Q3 | $16.7M | Sell |
157,025
-11,359
| -7% | -$1.11M | 1.44% | 11 |
|
|
2014
Q2 | $14M | Sell |
168,384
-12,671
| -7% | -$986K | 1.19% | 18 |
|
|
2014
Q1 | $12.8M | Buy |
181,055
+24,358
| +16% | +$1.91M | 1.05% | 28 |
|
|
2013
Q4 | $11.8M | Buy |
156,697
+6,886
| +5% | +$479K | 1.06% | 29 |
|
|
2013
Q3 | $9.41M | Buy |
149,811
+117,064
| +357% | +$7M | 1.13% | 35 |
|
|
2013
Q2 | $1.68M | Buy |
+32,747
| New | +$1.71M | 0.22% | 101 |
|
Other funds holding GILD
LS Investment Advisors's GILD Position: Q2 2021 in Review
LS Investment Advisors sold out of Gilead Sciences (GILD) in Q2 2021, closing a stake of 47,829 shares — an estimated $3.09M sold.
LS Investment Advisors first reported a position in GILD in Q2 2013 and held it in 32 quarters. The position peaked at $16.7M in Q3 2014. 1,544 funds tracked by Wall St. Rank hold GILD as of Q2 2021.
- LS Investment Advisors reported no remaining Gilead Sciences position as of Q2 2021 after selling out during the quarter.
- LS Investment Advisors sold 47,829 Gilead Sciences shares in Q2 2021, an estimated $3.09M.
- LS Investment Advisors first reported a position in Gilead Sciences in Q2 2013 and held it in 32 quarters.
- LS Investment Advisors's Gilead Sciences position peaked at $16.7M in Q3 2014.
- 1,544 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2021.
Based on LS Investment Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.